نتایج جستجو برای: adenovector

تعداد نتایج: 63  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2004
Arno J Mundt Srinivasan Vijayakumar John Nemunaitis Alan Sandler Herbert Schwartz Nader Hanna Terrence Peabody Neil Senzer Karen Chu Camilla S Rasmussen Paul D Kessler Henrik S Rasmussen Michael Warso Donald W Kufe Tapas Das Gupta Ralph R Weichselbaum

PURPOSE TNFerade is a second-generation replication-deficient adenovector carrying a transgene encoding human tumor necrosis factor alpha under control of a radiation- induced promoter. The objective of this study was to assess the tolerance of combining TNFerade and radiation therapy in patients with soft tissue sarcomas of the extremity. EXPERIMENTAL DESIGN TNFerade was administered in comb...

2012
Hongchao Zhou Xinyuan Dong Rafi Kabarriti Yong Chen Yesim Avsar Xia Wang Jianqiang Ding Laibin Liu Ira J. Fox Jayanta Roy-Chowdhury Namita Roy-Chowdhury Chandan Guha

BACKGROUND AND AIMS Preparative hepatic irradiation (HIR), together with mitotic stimulation of hepatocytes, permits extensive hepatic repopulation by transplanted hepatocytes in rats and mice. However, whole liver HIR is associated with radiation-induced liver disease (RILD), which limits its potential therapeutic application. In clinical experience, restricting HIR to a fraction of the liver ...

2011
Cindy Tamminga Martha Sedegah David Regis Ilin Chuang Judith E. Epstein Michele Spring Jose Mendoza-Silveiras Shannon McGrath Santina Maiolatesi Sharina Reyes Victoria Steinbeiss Charlotte Fedders Kathryn Smith Brent House Harini Ganeshan Jennylynn Lejano Esteban Abot Glenna J. Banania Renato Sayo Fouzia Farooq Maria Belmonte Jittawadee Murphy Jack Komisar Jackie Williams Meng Shi Donald Brambilla Nalini Manohar Nancy O. Richie Chloe Wood Keith Limbach Noelle B. Patterson Joseph T. Bruder Denise L. Doolan C. Richter King Carter Diggs Lorraine Soisson Daniel Carucci Gail Levine Sheetij Dutta Michael R. Hollingdale Christian F. Ockenhouse Thomas L. Richie

BACKGROUND A protective malaria vaccine will likely need to elicit both cell-mediated and antibody responses. As adenovirus vaccine vectors induce both these responses in humans, a Phase 1/2a clinical trial was conducted to evaluate the efficacy of an adenovirus serotype 5-vectored malaria vaccine against sporozoite challenge. METHODOLOGY/PRINCIPAL FINDINGS NMRC-MV-Ad-PfC is an adenovirus vec...

2010
Laurence Peiperl Cecilia Morgan Zoe Moodie Hongli Li Nina Russell Barney S. Graham Georgia D. Tomaras Stephen C. De Rosa M. Juliana McElrath

BACKGROUND Individuals without prior immunity to a vaccine vector may be more sensitive to reactions following injection, but may also show optimal immune responses to vaccine antigens. To assess safety and maximal tolerated dose of an adenoviral vaccine vector in volunteers without prior immunity, we evaluated a recombinant replication-defective adenovirus type 5 (rAd5) vaccine expressing HIV-...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2004
Dietmar Jacob John Davis Hongbo Zhu Lidong Zhang Fuminori Teraishi Shuhong Wu Frank C Marini Bingliang Fang

An adenoviral vector with RGD-modified fibers and expressing the human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene from the human telomerase reverse transcriptase (hTERT) promoter (designated Ad/TRAIL-F/RGD) was constructed, and its antitumor activity was evaluated in vitro and in vivo. An in vitro study showed that treatment with Ad/TRAIL-F/RGD elicited a high rate of ...

Ali Akbar Pourfathollah, Fereidoun Mahboudi, Hamid Reza Khorram Khorshid Kooroosh Kamali Mahtab Alinezhad Maryam Foroughi Minoo Mohraz Sayeed Bayanolhagh

Background: Numerous evidences indicate that in some HIV-1 positive patients, the humoral and cellular immune responses are induced against HIV-1 proteins and this is inversely related to the progress of infection. Objective: The aim of this study was the evaluation of the Adenovectors containing HIV genes in induction of immune responses in mice. Methods: The HIV-1 genes including gag p24, rev...

Journal: :PLoS ONE 2009
Tara Elvang Jan P. Christensen Rolf Billeskov Truc Thi Kim Thanh Hoang Peter Holst Allan Randrup Thomsen Peter Andersen Jes Dietrich

BACKGROUND Although CD4 T cells are crucial for defense against M.tb, it is still not clear whether the optimal response against M.tb in fact involves both CD4 and CD8 T cells. To test this, we used a new vaccine strategy that generated a strong balanced T cell response consisting of both CD4 and CD8 T cells. METHODS AND FINDINGS To compare CD4 and CD8 responses against Ag85B-TB10.4 (H4), H4 ...

Journal: :American journal of respiratory cell and molecular biology 2000
O Morikawa T A Walker L D Nielsen T Pan J L Cook R J Mason

Alveolar type II cell proliferation occurs after lung injury and is thought to minimize the subsequent fibrotic response. Keratinocyte growth factor (KGF) has been shown to be a potent growth factor for rat alveolar type II cells. In this study, we created a replication-deficient, recombinant human type 5 adenovirus vector expressing human KGF (Ad5-KGF) to produce alveolar type II cell hyperpla...

Journal: :Blood 1998
B M Frey N R Hackett J M Bergelson R Finberg R G Crystal M A Moore S Rafii

Replication-deficient adenoviral vectors (AdVec), which infect cycling and noncycling cells with high efficiency, low toxicity, and ease of delivery, provide ideal vehicles to study the expression of regulatory genes controlling different stages of hematopoiesis. To examine the infection efficiency of AdVec in hematopoietic precursor and progenitor cells, we used a replication-deficient adenove...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید